Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study

Brian K. Link, Bann mo Day, Xiaolei Zhou, Andrew D. Zelenetz, Keith L. Dawson, James R Cerhan, Christopher R. Flowers, Jonathan W. Friedberg

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)660-663
Number of pages4
JournalBritish Journal of Haematology
Volume184
Issue number4
DOIs
StatePublished - Feb 1 2019

Fingerprint

Follicular Lymphoma
Therapeutics
Rituximab

Keywords

  • B-cell neoplasms
  • clinical results in lymphoma
  • immunotherapeutic approaches
  • rituximab
  • treatment patterns

ASJC Scopus subject areas

  • Hematology

Cite this

Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States : data from the observational National LymphoCare Study. / Link, Brian K.; Day, Bann mo; Zhou, Xiaolei; Zelenetz, Andrew D.; Dawson, Keith L.; Cerhan, James R; Flowers, Christopher R.; Friedberg, Jonathan W.

In: British Journal of Haematology, Vol. 184, No. 4, 01.02.2019, p. 660-663.

Research output: Contribution to journalLetter

Link, Brian K. ; Day, Bann mo ; Zhou, Xiaolei ; Zelenetz, Andrew D. ; Dawson, Keith L. ; Cerhan, James R ; Flowers, Christopher R. ; Friedberg, Jonathan W. / Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States : data from the observational National LymphoCare Study. In: British Journal of Haematology. 2019 ; Vol. 184, No. 4. pp. 660-663.
@article{6114a427110646c69d2461fca0150205,
title = "Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study",
keywords = "B-cell neoplasms, clinical results in lymphoma, immunotherapeutic approaches, rituximab, treatment patterns",
author = "Link, {Brian K.} and Day, {Bann mo} and Xiaolei Zhou and Zelenetz, {Andrew D.} and Dawson, {Keith L.} and Cerhan, {James R} and Flowers, {Christopher R.} and Friedberg, {Jonathan W.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1111/bjh.15149",
language = "English (US)",
volume = "184",
pages = "660--663",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Second-line and subsequent therapy and outcomes for follicular lymphoma in the United States

T2 - data from the observational National LymphoCare Study

AU - Link, Brian K.

AU - Day, Bann mo

AU - Zhou, Xiaolei

AU - Zelenetz, Andrew D.

AU - Dawson, Keith L.

AU - Cerhan, James R

AU - Flowers, Christopher R.

AU - Friedberg, Jonathan W.

PY - 2019/2/1

Y1 - 2019/2/1

KW - B-cell neoplasms

KW - clinical results in lymphoma

KW - immunotherapeutic approaches

KW - rituximab

KW - treatment patterns

UR - http://www.scopus.com/inward/record.url?scp=85060100881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060100881&partnerID=8YFLogxK

U2 - 10.1111/bjh.15149

DO - 10.1111/bjh.15149

M3 - Letter

C2 - 29611177

AN - SCOPUS:85060100881

VL - 184

SP - 660

EP - 663

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -